How much funding has Harmony Biosciences raised?

Harmony Biosciences has raised $295.0M in total funding, most recently a Venture Round.

Who are Harmony Biosciences's investors?

Harmony Biosciences's investors include Valor Equity Partners, Nan Fung Life Sciences.

When was Harmony Biosciences founded?

Harmony Biosciences was founded in 2017.

Where is Harmony Biosciences headquartered?

Harmony Biosciences is headquartered in Plymouth Meeting, Pennsylvania, United States.

What industry is Harmony Biosciences in?

Harmony Biosciences operates in Biotech, Healthcare.

How many employees does Harmony Biosciences have?

Harmony Biosciences has 201-500 employees.

Harmony Biosciences

IPO

Harmony Biosciences & Newrology: A Fresh Approach

Public · Plymouth Meeting, United States · Founded 2017 · $295.0M raised

Biotech

Healthcare

Headquarters: Plymouth Meeting, Pennsylvania
Employees: 201–500
Founded: 2017
Business Model: B2B
Website: harmonybiosciences.com

Total Funding: $295.0M
Last Round: $25.0M Venture RoundJan 2018
Rounds: 2
Type: Public

About

Harmony Biosciences is a commercial-stage pharmaceutical company founded in 2017 and focused on developing and commercializing innovative therapies for people living with rare neurological diseases. The company received FDA approval for its first product in 2019, went public on NASDAQ in 2020, and has since expanded into rare epilepsy through the acquisitions of Zynerba Pharmaceuticals (2023) and Epygenix Therapeutics (2024). Its Newrology platform integrates patient, family, and scientific perspectives to advance unmet needs in sleep/wake disorders and rare epilepsy.

Summary

Harmony Biosciences is a Biotech company based in Plymouth Meeting, United States, founded in 2017. It has raised $295.0M in total across 2 rounds, most recently a $25.0M Venture Round round in Jan 2018. Investors include Valor Equity Partners and Nan Fung Life Sciences.

LinkedIn X (Twitter)